AIDS and 9/11

7. Gary Null “The 2729 AIDS Doubters,” http://www.garynull.com/home/the-2729-AIDS-doubters.html

8. John Lauritsen, “AIDS” http://paganpressbooks.com/jpl/AIDS.HTM, http://www.liquida.com/page/9290904/

9. See for example, Nancy S. Padian,1 Stephen C. Shiboski,2 Sarah O. Glass,1 and Eric Vittinghoff3,” Heterosexual Transmission of Human Immunodeficiency Virus (HIV) in Northern California: Results from a Ten-year Study”

http://aje.oxfordjournals.org/content/146/4/350.full.pdf+html

Gary Null, “AIDS a Second Opinion,” Seven Stories Press 2002, p118

10. Human genome, http://en.wikipedia.org/wiki/Human_genome

11. James D. Watson, DNA, The Secret of Life, Alfred A. Knoph, New York, p 76.

12. Janine Roberts, “Fear of the Invisible,” Impact Investigative Media Productions, Bristol, UK, p242-246.

13. Henry H. Bauer, “The Origin, Persistence and Failings of the HIV/AIDS Theory,” McFarland & Company, Inc., Jefferson, North Carolina and London, p 147.

14. 11. James D. Watson, “DNA, The Secret of Life,” Alfred A. Knoph, New York, p 356

15. Enzyme Essentials http://www.enzymeessentials.com/HTML/proteases.html

16. Henry H. Bauer, “The Origin, Persistence and Failings of the HIV/AIDS Theory,” McFarland & Company, Inc., Jefferson, North Carolina and London, p 3.

17. http://www.thefreedictionary.com/reverse+transcriptase

18. http://www.aidsmeds.com/list.shtml

19. Etienne de Harven, “Ten Lies about AIDS,” Trafford, North America and International, p 52.

20. Janine Roberts, “Fear of the Invisible,” Impact Investigative Media Productions, Bristol, UK, p209.

21. ibid, p 208.

22. ibid, p 129.

23. The 4 papers which claim to show that HIV causes AIDS:

Popovic M, Sarngadharan MG, Read E, Gallo RC. (1984) Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS.Science 224: 497-500 (4 May 1984)

Gallo RC, Salahuddin SZ, Popovic M, Shearer GM, Kaplan M, Haynes BF, Palker TJ, Redfield R, Oleske J, Safai B, et al. “Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS,” Science 224, 500-3 (4 May 1984).

Schüpbach J, Popovic M, Gilden RV, Gonda MA, Sarngadharan MG, Gallo RC, Serological analysis of a subgroup of human T-lymphotropic retroviruses (HTLV-III) associated with AIDS. Science 224,503-5 (4 May 1984)

Sarngadharan MG, Popovic M, Bruch L, Schüpbach J, Gallo RC. (1984) Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS, Science 224, 506-8 (4 May 1984)

24. Janine Roberts, “Fear of the Invisible,” Impact Investigative Media Productions, Bristol, UK, p141.

25. Janine Roberts, HIVGATE, http://www.sparks-of-light.org/HIVGATE%20-%20review%20copy.pdf

26. Etienne de Harven, Rethinking Aids 2009, Oakland California, http://www.youtube.com/watch?v=aqln30Xn9NA

27. http://www.garynull.com/home/top-scientists-ask-journal-science-to-retract-original-AIDS.html

28. See for example Christine Maggiore, “Is the ‘AIDS Test’ Accurate?” http://www.healtoronto.com/testcm.html

29. Christine Johnson, “Viral Load and the PCR,” Continuum Nov. 2001, http://www.virusmyth.com/aids/hiv/chjtests5.htm

30. Etienne de Harven, at Rethinking Aids, Oakland November 11, 2010 http://www.youtube.com/watch?v=aqln30Xn9NA

31. Roswitha Lower, Johannes Lower, Reinhard Kurth, “The viruses in all of us: Characteristics and biological significance of human endogenous retrovirus sequences,” Proc. Natl. Acad. Sci. USA,93, 5177-5184, May 1996. http://www.pnas.org/content/93/11/5177.full.pdf

32. P N Nelson et al, “Demystified . . . Human endogenous retroviruses,” Mol Pathol. 2003 February; 56(1): 11–18. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1187282/

33. Janine Roberts, “Fear of the Invisible,” Impact Investigative Media Productions, Bristol, UK, p201.

34. Henry H. Bauer, “The Origin, Persistence and Failings of the HIV/AIDS Theory,” McFarland & Company, Inc., Jefferson, North Carolina and London, Chapter 9.

35. Rebecca Culshaw, “Science Sold Out,” North Atlantic Books, Berkeley, California, 2007 p 19.

36. Russell Schoch, “A Letter to my Son’s Doctor,” April 1999, http://www.virusmyth.com/aids/news/rsletterdoc.htm

37. Celia Farber, “Science Fiction, Gear Magazine, March 2000. http://www.virusmyth.com/aids/hiv/cffiction.htm

38. Gary Null, “AIDS a Second Opinon,” Seven Stories Press 2002, p 119.

39. Etienne de Harven, “Ten Lies about AIDS,” Trafford, North America and International, p 82.

40. ibid. p 84.

41. See for example: “A Powerful and Perplexing New HIV Prevention Tool,” Science 330, 1298, 12/3/2010

42. David M Murdoch et al, Immune reconstitution inflammatory syndrome (IRIS): review of common infectious manifestations and treatment options. http://www.aidsrestherapy.com/content/4/1/9

43. Rethinking Aids, Item #50: Does HIV Kill T-Cells? http://www.rethinkingaids.com/gallorebuttal/Farber-Gallo-50.html

44. Janine Roberts, “Fear of the Invisible,” Impact Investigative Media Productions, Bristol, UK, Chapters 3-7.

45. Jim West, “Images of Poliomyelitis,” file:///D:/Polio%205%20Jim%20West.htm.

46. “Images of Poliomyelitis,” http://www.vaclib.org/sites/harpub/pol_all.htm.

47. Gary Null, “AIDS a Second Opinion,” Seven Stories Press 2002, p 315.

48. ibid. p 313.

49. Testimony of Howard B. Urnovitz, Ph.D. (1/24/02) U.S. House of Representatives

http://www.whale.to/v/urnovitz7.html

50. Janine Roberts, “Fear of the Invisible,” Impact Investigative Media Productions, Bristol, UK, p 66.

51. Gary Null, “AIDS a Second Opinion,” Seven Stories Press 2002, p 417.

52. ibid, p 415.

53. John Lauritsen, “FDA Documents Show Fraud on AZT Trials,” New York Native, March 30, 1992 http://www.reviewingaids.com/awiki/index.php/Document:FDA_Documents_Show_Fraud

54. “Drugs, Disease, Denial,” New York Press June 29, 2005

http://www.nypress.com/article-11728-drugs-disease-denial.html

55. Celia Farber, “Out of Control: Aids and the Corruption of Medical Science,”

http://www.harpers.org/archive/2006/03/0080961

56. See for example: “The Tuskegee Syphilis Experiment”

http://www.infoplease.com/ipa/A0762136.html

57. “Unethical human experimentation in the United States.”

http://en.wikipedia.org/wiki/Unethical_human_experimentation_in_the_United_States

58. See for example: Olaniyi O Taiwo and Zuwaira Hassan, “The impact of Highly Active Antiretroviral Therapy (HAART) on the clinical features of HIV – related oral lesions in Nigeria”

http://preview.aidsrestherapy.com/content/7/1/19/abstract

59. Karri Stokely, Rethinking Aids Conference, Oakland CA 2009

http://www.youtube.com/watch?v=BK7bmK-quVs

60. The Antiretroviral Therapy (ART) Cohort Collaboration , “HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis,” The Lancet, Volume 368, Issue 9534, Pages 451 – 458, 5 August 2006

61. The Antiretroviral Therapy Cohort Collaboration, “Causes of Death in HIV-1–Infected Patients Treated with Antiretroviral Therapy, 1996–2006: Collaborative Analysis of 13 HIV Cohort Studies,”

http://www.hivma.org/uploadedFiles/HIVMA/Publications/Annual_Compendia_of_CID_Articles_on_HIV/2010/013.pdf

62. Social Security Online, Actuarial Publications

http://www.ssa.gov/OACT/STATS/table4c6.html

63. ART-CC. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet 2008; 372:293–299.

http://www.thelancet.com/journals/lancet/article/PIIS0140673608611137/abstract

64. Quality-Of-Life Predicts Survival in HIV: HIV & aging, CID Jan 15 2010

http://www.natap.org/2010/HIV/011710_01.htm

65. Michael Carter, “Starting HIV treatment reduces risk of death from all causes; additional benefits if treatment started sooner,” http://www.AIDSmap.com/page/1437311/

66. “Patterns and Correlates of Discontinuation of the Initial HAART Regimen in an Urban Outpatient Cohort” http://www.natap.org/2003/dec/121303_2.htm

67. Gregory P. Bisson et al, “Overestimates of Survival after HAART: Implications for Global Scale-Up Efforts,” http://www.plosone.org/article/info:doi/10.1371/journal.pone.0001725

68. Peter Duesberg et al, “The chemical bases of the various AIDS epidemics: recreational

drugs, anti-viral chemotherapy and malnutrition”

http://www.virusmyth.com/AIDS/hiv/pddrchemical.pdf

69. Roger Collier, “Drug development cost estimates hard to swallow,” CMAJ. 2009 February 3; 180(3): 279–280. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2630351/

70. Henry H. Bauer, Ph.D., “Incongruous Age Distributions of HIV Infections and

Deaths from HIV Disease: Where Is the Latent Period Between HIV Infection and AIDS?,”

http://www.jpands.org/vol13no3/bauer.pdf

71. Henry H. Bauer, “The Origin, Persistence and Failings of the HIV/AIDS Theory,” McFarland & Company, Inc., Jefferson, North Carolina and London, Chapters 1-6.

72. ibid p30.

73. Celia Farber, “Serious adverse Events,” Melville House Publishing, Hoboken, New Jersey, 2006, p 187.

74. David Brown, “Number of People Getting Lifesaving HIV Drugs Rises,” Washington Post, 10/1/09

http://www.washingtonpost.com/wp-dyn/content/article/2009/09/30/AR2009093004884.html

75. Gary Null, “AIDS a Second Opinon,” Seven Stories Press 2002, p561-573.

76. Gary Null, HIV Equals AIDS and Other Myths of the AIDS War

http://www.garynull.com/home/hiv-equals-AIDS-and-other-myths-of-the-AIDS-war.html

77. David Crowe, “Lost Aids: Luc Montagnier’s HIV

http://aras.ab.ca/articles/popular/20091201-Montagnier.html

78. Etienne de Harven, “Ten Lies about AIDS,” Trafford, North America and International, p 31-33.